Adaptive Biotechnologies Corporation ADPT

29.43 (0.14) (0.47%) as of 25 Sep
Market cap
$4.7B
P/E
0.0×
Growth Flags show if company had growth for consecutive years

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments
192.15 165.02 576.87 688.27 353.06 498.20 346.40 222.29 226.98
Receivables
5.58 4.81 12.68 10.05 17.41 40.06 37.97 41.73 50.37
Inventory
4.79 7.84 9.07 14.06 19.26 14.45 14.45 8.44 9.82
Total current assets
205.25 180.72 612.69 726.91 402.75 562.15 410.19 283.75 300.19
Property, Plant, Equpment (Net)
13.95 19.13 60.36 39.69 85.26 83.45 68.23 48.62 34.11
Long-Term Investments
8.91 0.00 105.44 118.53 217.15 2.00 — 33.66 13.23
Goodwill and Intangible Assets (Total)
134.30 132.60 130.90 129.20 127.50 125.80 124.10 122.40 120.70
Long-term assets (Other)
0.09 0.25 2.92 2.74 3.01 4.46 6.52 5.18 3.90
Total non-current assets
157.24 151.97 299.61 389.50 520.60 294.47 250.95 255.62 212.55
Total Assets
362.49 332.69 912.30 1,116.41 923.34 856.62 661.13 539.38 512.74
Accounts Payable
1.96 1.79 4.45 3.24 3.31 8.08 7.72 7.27 6.47
Accrued Expenses
4.11 7.20 12.50 25.11 24.99 28.36 22.28 24.00 24.69
Current Revenue (Deferred)
14.93 13.80 61.37 73.32 80.46 64.12 48.63 55.69 45.19
Other current liabilities
19.00 21.00 74.00 98.00 105.00 92.00 — 0.87 4.64
Total current liabilities
21.00 22.80 78.31 105.20 113.81 109.79 88.02 98.05 89.92
Long Term Debt (Total)
562.00 561.00 36.61 104.00 107.00 224.00 — — —
Non-current Revenue (Deferred)
4.39 6.81 226.25 163.62 98.75 58.60 44.79 27.26 1.01
Liabilities (Preferred Stock)
0.34 0.34 — — — — — — —
Non-current Liabilities (Other)
0.03 6.00 0.09 0.00 — 125.36 130.66 132.43 126.59
Total non-current liabilities
4.77 7.14 262.95 267.95 205.44 282.73 264.84 238.84 197.82
Total liabilities
25.77 29.94 341.26 373.15 319.24 392.52 352.86 336.89 287.74
Additional Paid In Capital
24.97 37.90 935.83 1,253.97 1,324.01 1,387.35 1,452.50 1,506.35 1,581.85
Preferred Stock (Total)
561.33 560.86 — — — — — — —
Common Stock (Net)
0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.02
Retained Earnings
(249.42) (295.91) (365.48) (511.61) (718.89) (919.08) (1,144.33) (1,303.82) (1,363.32)
Common Equity (Total)
(224.62) (258.11) 571.04 743.27 604.10 464.10 308.28 202.49 225.00
Shareholders Equity (Total)
336.72 302.75 571.04 743.27 604.10 464.10 308.28 202.49 225.00
Shareholders Equity and Liabilities (Total)
362.49 332.69 912.30 1,116.41 923.34 856.62 661.13 539.38 512.74
Shares (Common)
12.21 12.84 125.24 137.65 141.39 143.11 145.08 147.77 153.78
Shares (Preferred)
92.66 92.79 — — — — — — —
Shareholders Equity (Tangible)
202.42 170.15 440.14 614.07 476.60 338.30 184.18 80.09 104.30
Net Debt
369.85 395.98 (540.26) (584.27) (246.06) (274.20) (346.40) (222.29) (226.98)
Total Debt
562.00 561.00 36.61 104.00 107.00 224.00 — — —

Fold the line items

In millions of $ except per-share values · columns are period end dates